Literature DB >> 24937066

Drug monitoring: bright lights yield drug readout.

Lei Ge1, Jinghua Yu1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24937066     DOI： 10.1038/nchembio.1562

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  9 in total

1.  Integrated separation of blood plasma from whole blood for microfluidic paper-based analytical devices.

Authors:  Xiaoxi Yang; Omid Forouzan; Theodore P Brown; Sergey S Shevkoplyas
Journal:  Lab Chip       Date:  2011-11-17       Impact factor: 6.799

Review 2.  Current role of LC-MS in therapeutic drug monitoring.

Authors:  Franck Saint-Marcoux; François-Ludovic Sauvage; Pierre Marquet
Journal:  Anal Bioanal Chem       Date:  2007-05-23       Impact factor: 4.142

Review 3.  Microfluidic paper-based devices for bioanalytical applications.

Authors:  Murilo Santhiago; Emilia W Nery; Glauco P Santos; Lauro T Kubota
Journal:  Bioanalysis       Date:  2014-01       Impact factor: 2.681

4.  Diagnostics for the developing world: microfluidic paper-based analytical devices.

Authors:  Andres W Martinez; Scott T Phillips; George M Whitesides; Emanuel Carrilho
Journal:  Anal Chem       Date:  2010-01-01       Impact factor: 6.986

5.  Sensing approaches on paper-based devices: a review.

Authors:  Emilia W Nery; Lauro T Kubota
Journal:  Anal Bioanal Chem       Date:  2013-04-23       Impact factor: 4.142

6.  Luminescence resonance energy transfer-based nucleic acid hybridization assay on cellulose paper with upconverting phosphor as donors.

Authors:  Feng Zhou; M Omair Noor; Ulrich J Krull
Journal:  Anal Chem       Date:  2014-02-18       Impact factor: 6.986

7.  Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring.

Authors:  Rudolf Griss; Alberto Schena; Luc Reymond; Luc Patiny; Dominique Werner; Christine E Tinberg; David Baker; Kai Johnsson
Journal:  Nat Chem Biol       Date:  2014-06-08       Impact factor: 15.040

Review 8.  Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.

Authors:  Bruce N Cronstein
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

9.  Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

Authors:  Barbara L Asselin; Meenakshi Devidas; Chenguang Wang; Jeanette Pullen; Michael J Borowitz; Robert Hutchison; Steven E Lipshultz; Bruce M Camitta
Journal:  Blood       Date:  2011-04-07       Impact factor: 22.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.